Log In
Print this Print this

Ragweed Allergy Immunotherapy Tablet (AIT) (Ragwitek) (MK-3641) (formerly SCH 039641)

  Manage Alerts
Collapse Summary General Information
Company ALK-Abello A/S
DescriptionTablet-based sublingual allergen immunotherapy
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsTreat ragweed-induced allergic rhinitis; Treat ragweed-induced rhinoconjunctivitis
Regulatory Designation U.S. - Undisclosed Review (Treat ragweed-induced allergic rhinitis);
Canada - Standard Review (Treat ragweed-induced allergic rhinitis)
Partner Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today